Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ...

ClearPoint Neuro (CLPT) “announced the U.S. Food and Drug Administration has granted marketing authorization for the SmartFlow Neuro ...

Q3 2024 Earnings Call Transcript November 7, 2024 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0 ...

ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

This was the 10th Paediatric Neuropsychology Workshop, which was intended to focus on the unique needs of children with ...

ClearPoint Neuro develops and commercializes platforms for performing minimally invasive surgical procedures in the brain.

Study findings could serve as a foundation for broader neuro-monitoring applications across intensive care units globally.

Plenary Oral Presentation at SNO will provide latest clinical trial results from the previously enrolled INB-200 studies of ...

And to do so, we developed a novel personalized method that combines neuro-navigation, of course, for precision targeting within the precuneus, and especially a combination of TMS with ...

“It fills me with hope in a way that is hard to put into words that at least one child on this trial appears to be tumor-free ...

A big night for a group of Delaware County athletes as they took to the basketball court for their final game of the season.

ClearPoint Neuro ( (CLPT) ) just unveiled an update. ClearPoint Neuro reported a strong third quarter in 2024 with a 41% increase in revenue, ...